MDxHealth (NASDAQ: MDXH) director reports 10,000-share option grant

Rhea-AI Filing Summary

MDxHealth SA director Michael Holder reports initial holdings of share options. The filing shows options to purchase 10,000 ordinary shares at an exercise price of $2.18 per share, granted on June 27, 2025. These options vest in full at the annual general shareholders' meeting held in the calendar year after the grant year and expire on June 27, 2035.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Holder Michael

Role Director

Type	Security	Shares	Price	Value
holding	Share Option	--	--	--

Holdings After Transaction: Share Option — 10,000 shares (Direct)

Footnotes (1)

1. F1. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $2.18 granted on June 27, 2025 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 03/18/2026 - 07:57 PM Learn about SEC filing dates

FAQ

What does the MDxHealth (MDXH) Form 3 filing by Michael Holder report?

The Form 3 reports Michael Holder’s initial beneficial ownership in MDxHealth. It discloses a grant of options over 10,000 ordinary shares at $2.18 per share, vesting after a future annual general shareholders’ meeting and expiring on June 27, 2035.

How many MDxHealth (MDXH) shares are covered by Michael Holder’s options?

Michael Holder holds options over 10,000 MDxHealth ordinary shares. These options give him the right, but not the obligation, to buy 10,000 shares at a fixed exercise price of $2.18 per share before they expire on June 27, 2035.

What is the exercise price and expiry of Michael Holder’s MDxHealth (MDXH) options?

The options have an exercise price of $2.18 per MDxHealth ordinary share and expire on June 27, 2035. This means he can choose to buy the 10,000 underlying shares at $2.18 any time before that expiration date, subject to vesting.

When do Michael Holder’s MDxHealth (MDXH) options vest?

The options vest in full on the date of the annual general shareholders' meeting held in the calendar year after the year of grant. Since they were granted on June 27, 2025, vesting occurs at the first annual meeting in the following calendar year.

Is the MDxHealth (MDXH) Form 3 a buy or sell transaction?

The Form 3 is not a buy or sell transaction. It is an initial ownership report showing that director Michael Holder holds options over 10,000 MDxHealth ordinary shares as part of his equity compensation, with a set exercise price and vesting schedule.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Holder Michael

(Last) (First) (Middle)

CAP BUSINESS CENTER

ZONE INDUSTRIELLE DES HAUTS-SARTS

(Street)

HERSTAL 4040

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
MDxHealth SA [ MDXH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option	(1)	06/27/2035	Ordinary Shares	10,000	$2.18	D

Explanation of Responses:

1. Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $2.18 granted on June 27, 2025 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.

	/s/ Mark Busch, as attorney-in-fact for Michael Holder	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)